| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Blood-Based Measurable Residual Disease by Clonotypic Mass Spectrometry is Prognostic in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
|
Slade, Michael J.
|
|
|
25 |
9 |
p. e628-e637.e4
|
artikel
|
| 2 |
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease Progression
|
Aguirre, Luis E.
|
|
|
25 |
9 |
p. 661-671
|
artikel
|
| 3 |
Clinical Perspectives on Amyloidosis in India: A Systematic Literature Review
|
Mirgh, Sumeet
|
|
|
25 |
9 |
p. e675-e684
|
artikel
|
| 4 |
Clinicians’ Perspectives and Methodological Application of Fluorescence in situ Hybridization (FISH) to Define Cytogenetic Risk in Multiple Myeloma: An Italian, Real-World, Survey-Based Report From the European Myeloma Network (EMN) Italy
|
Cani, Lorenzo
|
|
|
25 |
9 |
p. 676-683.e11
|
artikel
|
| 5 |
Comparing Outcomes of First-Line Intensive Chemotherapeutic Regimens in Adult Patients With Acute Lymphoblastic Leukemia at a Tertiary Center
|
Mohamed, Ahmed
|
|
|
25 |
9 |
p. e668-e674.e9
|
artikel
|
| 6 |
Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in India
|
Gajendra, Smeeta
|
|
|
25 |
9 |
p. e685-e695.e17
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
25 |
9 |
p. A1-A2
|
artikel
|
| 8 |
Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma
|
Chari, Ajai
|
|
|
25 |
9 |
p. 635-645
|
artikel
|
| 9 |
Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract
|
Scott, Sara A
|
|
|
25 |
9 |
p. 656-660
|
artikel
|
| 10 |
Feasibility of Bruton’s Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient Perspective
|
Stephens, Deborah M.
|
|
|
25 |
9 |
p. e663-e667
|
artikel
|
| 11 |
Heavy Chain Cast Nephropathy in a Gamma Heavy Chain Disease: RESPONSE to High-Dose Therapy Melphalan and Daratumumab
|
Al-Sawajneh, Suhaib
|
|
|
25 |
9 |
p. e704-e708
|
artikel
|
| 12 |
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Relapsed or Refractory Lymphoma
|
Soto, Felipe
|
|
|
25 |
9 |
p. e649-e655
|
artikel
|
| 13 |
Inferior Outcomes in Acute Lymphoblastic Leukemia With Translocation (14;18)
|
Habib, Diane
|
|
|
25 |
9 |
p. 672-675
|
artikel
|
| 14 |
Monoclonal Gammopathies in Africa
|
Bolarinwa, Abiola
|
|
|
25 |
9 |
p. e696-e703.e2
|
artikel
|
| 15 |
Moving Towards the Delivery of Outpatient T-Cell Engaging Therapy for the Management of Multiple Myeloma
|
Rosenberg, Maya
|
|
|
25 |
9 |
p. e709-e720
|
artikel
|
| 16 |
Outcomes of Adolescent LBCL Patients Treated With Adult Type Chemotherapy: A Single Center Experience
|
El Fakih, Riad
|
|
|
25 |
9 |
p. e613-e618
|
artikel
|
| 17 |
Outcomes of Patients With Extramedullary Disease in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma From the Pooled LocoMMotion and MoMMent Studies
|
Moreau, Philippe
|
|
|
25 |
9 |
p. 646-655.e1
|
artikel
|
| 18 |
Racial and Socioeconomic Disparities in Cutaneous T-Cell Lymphoma Survival: Insights From the National Cancer Database
|
Allen, Pamela
|
|
|
25 |
9 |
p. e638-e648
|
artikel
|
| 19 |
Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma
|
Higué, Jules
|
|
|
25 |
9 |
p. 684-688.e4
|
artikel
|
| 20 |
Role of a Multidisciplinary Program (Amyloidosis Program of Calgary) on Recognition and Intervention for AL and ATTR Amyloidosis
|
Burande, Aksha
|
|
|
25 |
9 |
p. e619-e627
|
artikel
|
| 21 |
SOHO State of the Art Updates and Next Questions | Manuscript Title: Bispecific T-Cell Engagers: Sequencing, B-Cell Maturation Antigen, GPRC5D, and Resistance
|
Ayyappan, Sabarish
|
|
|
25 |
9 |
p. 625-634
|
artikel
|
| 22 |
SOHO State of the Art Updates and Next Questions | Transplanting Hope: Managing Relapsed/Refractory AML
|
Funk, Christopher Ronald
|
|
|
25 |
9 |
p. 615-624
|
artikel
|
| 23 |
SOHO State of the Art Updates and Next Questions | Update on Tailoring Therapy in T Cell Lymphomas
|
Moe, Christina
|
|
|
25 |
9 |
p. e656-e662
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
25 |
9 |
p. A3-A6
|
artikel
|
| 25 |
Utilization Patterns and Outcomes From Iron Chelation Therapy in Elderly Patients With Myelodysplastic Syndromes: A Population Analysis
|
Strumilowska, Aneta
|
|
|
25 |
9 |
p. e721-e730.e3
|
artikel
|
Tijdschrift beschrijving